Global Oncology Academy
Popular
Jenny Seligmann, MBChB, PhD
Fortunato Ciardiello, MD, PhD
- Clinician's Roundtable
Etranacogene Dezaparvovec for Hemophilia B: Efficacy and Safety Four Years Post-Infusion
Brian P. McDonough, MD, FAAFP
Guy Young, MD
Peter Buch, MD, FACG, AGAF, FACP
Aasma Shaukat, MD, MPH
Daniel P. Petrylak, MD
Elizabeth R. Plimack, MD, MS, FASCO
Evan Y. Yu, MD
Charles Turck, PharmD, BCPS, BCCCP
Anthony Stein, MD
- Project Oncology®
Advancing Multiple Myeloma Treatment: The Role of Immunotherapy and Personalized Care
Shaji K. Kumar, MD
Medical News
medicalxpress.com
01/08/2025- sciencedaily.com
01/08/2025
- Medical NewsNew Technology Reverts Colon Cancer Cells to Normal-Like State Without Traditional Side Effectsnews-medical.net
01/08/2025
- news.uthscsa.edu
01/07/2025
CME/CE
- NEW EPISODEMinuteCE®
Mutational Testing in mCRC: Methods and Data Driving Treatment Selection
1.00 program creditFortunato Ciardiello, MD, PhD
Jenny Seligmann, MBChB, PhD
- NEW EPISODEMinuteCE®
Defining the Standard of Care and Optimal Sequencing in BRAF-Mutant mCRC: Second Line and Beyond
1.00 program creditFortunato Ciardiello, MD, PhD
Jenny Seligmann, MBChB, PhD
Elizabeth R. Plimack, MD, MS, FASCO
Shilpa Gupta, MD
Elizabeth R. Plimack, MD, MS, FASCO
Lillibeth Velasco, MSN, RN
Clinical Practice
Elizabeth R. Plimack, MD, MS, FASCO
Elizabeth R. Plimack, MD, MS, FASCO
Lillibeth Velasco, MSN, RN
Programs
Javier Cortes, MD, PhD
Hope S. Rugo, MD, FASCO
Brian P. McDonough, MD, FAAFP
John Mascarenhas, MD
Lucia Masarova, MD
- Project Oncology®
Understanding Anemia in Myelofibrosis: Multifactorial Origins and Management Strategies
Charles Turck, PharmD, BCPS, BCCCP
Prithviraj Bose, MD